Related Experiment Video
Updated: Aug 14, 2026

09:39
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Cellular interactions uncouple beta-adrenergic receptors from adenylate cyclase
Summary
C6 glioma cells lose their beta-adrenergic receptor response when co-cultured with B104 neuroblastoma cells. This suggests the beta receptor/adenylate cyclase signaling pathway in C6 cells becomes uncoupled.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- C6 glioma and B104 neuroblastoma cells exhibit distinct cellular signaling properties.
- C6 cells possess adenylate cyclase activity and beta-adrenergic receptors.
- B104 cells possess adenylate cyclase activity but lack beta-adrenergic receptors.
Purpose of the Study:
- To investigate the impact of co-culturing C6 glioma cells with B104 neuroblastoma cells on the beta-adrenergic receptor signaling pathway in C6 cells.
Main Methods:
- Co-culturing C6 glioma cells and B104 neuroblastoma cells.
- Stimulating cells with beta receptor agonists.
- Measuring adenosine 3', 5'-monophosphate (cAMP) accumulation.
- Assessing cholera toxin-stimulated adenylate cyclase activity.
Main Results:
- Co-cultured C6 cells demonstrated a significant reduction in cAMP accumulation upon stimulation with beta receptor agonists compared to non-co-cultured C6 cells.
- Both beta-adrenergic receptors and cholera toxin-stimulated adenylate cyclase activity were present in the C6/B104 co-cultures.
- The observed decrease in cAMP accumulation indicates a functional disruption in the signaling pathway.
Conclusions:
- The beta-adrenergic receptor/adenylate cyclase transduction mechanism in C6 glioma cells is uncoupled when co-cultured with B104 neuroblastoma cells.
- This uncoupling suggests an inhibitory interaction between the two cell types at the level of signal transduction.
- Further research is needed to elucidate the specific molecular mechanisms underlying this observed uncoupling.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

